---
DrugClass: "[[Immune Modulating Therapies]]"
SubClass: "[[Checkpoint inhibitors]]"
DrugClassAdverse: "[[Checkpoint inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Checkpoint inhibitors#Contraindications]]"
BrandName: Revlimid
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "51"
KindleLinkChap: "[Chapter 51](kindle://book?action=open&asin=B09FRF11YJ&location=30282)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Immunomodulatorsâ€”Angiogenesis Inhibitors
---
```smiles
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
[[Lymphoma]] reoccurrence, multiple [[myeloma]]


### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Fatigue, headache, dizziness, rash, edema, [[Epistaxis]] Lenalidomide, [[pomalidomide]], and [[thalidomide]] are administered under strict supervision in special programs because of the severe birth defects that occur if taken while pregnant

### Interactions

`= this.ChemLink+this.file.name`

